Paper published in a book (Scientific congresses and symposiums)
How many women can benefit from a full intrapartum antibiotic prphylaxis for prevention of perinatal group B streptococcal disease?
MELIN, Pierrette; Lorquet, Sophie; Rodriguez Cuns, Grisel et al.
2004In American Society of Microbiology (Ed.) Program and Abstracts of the 44th Intersciences Conference on Antimicrobial Agents and Chemotherapy
Peer reviewed
 

Files


Full Text
Time to delivery ICAAC 2004.pdf
Publisher postprint (499.19 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Group B streptococci; perinatal infections; intrapartum antibiotic prophylaxis; pregnant women
Abstract :
[en] Background: In Belgium as in many Western countries, GBS are still the leading cause of severe perinatal infections. Current guidelines for prevention recommend intrapartum antimicrobial prohylaxis (IAP) administered promptly before delivery to pregnant women colonized with GBS. The risk of vertical GBS transmission to the newborn decreases as the duration of prophylaxis increases. The considered threshold for prophylaxis adequacy is the first dose administered at least 4 hours before delivery. Objective: To evaluate the proportion of pregnant women who could benefit from an adequate IAP for the prevention of GBS perinatal infections. Methods: Between June and October 2003, we recorded in two hospitals the elapse time between admission for labor and delivery. We assumed 5 hours represent a useful threshold to allow admission, revision of chart and administration of adequate IAP. The status of vaginal colonization with GBS was determined by CDC’s recommended culture method with Granada agar added. Results: Among 532 women, 27.3 % delivered within 5 hours after admission for labor. The colonization rate for GBS was 25.6 %. The distribution of elapse time between admission and delivery for GBS colonized pregnant women was not significantly different from non colonized women (p <= 1). Conclusions: 1) With the current prevention strategy, 27.3 % of these pregnant women would not have benefit from adequate prophylaxis 2) These results highlight the importance of an efficient organization to warranty prompt administration of IAP as soon as possible when mandatory. 3) If a rapid intrapartum screening test is used, no delay can be afforded “from ward to bench to bed”.
Research center :
Centre National de Référence des Streptocoques du Groupe B
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Immunology & infectious disease
Author, co-author :
MELIN, Pierrette  ;  Centre Hospitalier Universitaire de Liège - CHU > Microbiologie médicale
Lorquet, Sophie
Rodriguez Cuns, Grisel;  Universitad de la Republica, Montevideo, Uruguay
Foidart, Jean-Michel ;  Université de Liège - ULiège > Gynécologie Obstétrique
De Mol, Patrick ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Microbiologie médicale et virologie médicale
Language :
English
Title :
How many women can benefit from a full intrapartum antibiotic prphylaxis for prevention of perinatal group B streptococcal disease?
Publication date :
November 2004
Event name :
44th Intersciences Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Event organizer :
American Society of Microbiology
Event place :
Washington, United States
Event date :
du 30 octobre au 2 novembre 2004
Audience :
International
Main work title :
Program and Abstracts of the 44th Intersciences Conference on Antimicrobial Agents and Chemotherapy
Editor :
American Society of Microbiology
Publisher :
American Society for Microbiology (ASM), Washington, United States
Pages :
Abstract du poster G-499
Peer reviewed :
Peer reviewed
Available on ORBi :
since 28 February 2011

Statistics


Number of views
72 (2 by ULiège)
Number of downloads
37 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi